Post-Notice of Compliance (NOC) Changes – Quality Guidance

This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to Section C.08.004 of the Food and Drug Regulations. This may include pharmaceuticals, biologics and radiopharmaceuticals for human use and pharmaceutical, radiopharmaceutical and certain biotechnological products for veterinary use.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-07-07

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data